
Epigral Limited
The current stock price of Epigral Limited is ₹1,723.00, with a target price range between ₹1,636.85 and ₹1,809.15. The stock has experienced a price change of ₹167.75 (10.79%), reflecting recent market volatility.
Today's opening price was ₹1,555.25, while the previous close stood at ₹1,555.25.
The market trend suggests an uptrend, making it an attractive investment opportunity for traders seeking short-term gains.
For real-time stock market updates, live share prices, and stock analysis, stay tuned. Understanding key stock metrics like VWAP, high-low range, and market momentum can help traders make informed investment decisions.
Epigral Limited Price Chart
Epigral Limited Pre Open Market Overview: 04-Mar-2025
Key Metrics:
- IEP (Indicative Equilibrium Price): 1555.25
- Previous Close Price: 1555.25
- Change: 0.00%
- Total Traded Volume: 368
- Total Buy Quantity: 872
- Total Sell Quantity: 182
Price | Buy Qty | Sell Qty |
---|---|---|
1,533.70 | 20.00 | 0.00 |
1,545.00 | 2.00 | 0.00 |
1,547.00 | 8.00 | 0.00 |
1,551.00 | 30.00 | 0.00 |
1,555.25 | 87.00 | 0.00 |
1,557.00 | 0.00 | 55.00 |
1,561.00 | 0.00 | 2.00 |
1,563.00 | 0.00 | 16.00 |
1,570.75 | 0.00 | 3.00 |
1,575.00 | 0.00 | 1.00 |
ATO Data:
- Buy Quantity (ATO): 0
- Sell Quantity (ATO): 0
Order Book
Bid | Qty | Ask | Qty |
---|---|---|---|
0.00 | 0 | 0.00 | 0 |
0.00 | 0 | 0.00 | 0 |
0.00 | 0 | 0.00 | 0 |
0.00 | 0 | 0.00 | 0 |
0.00 | 0 | 0.00 | 0 |
Shareholding Patterns of Epigral Limited
Key Trade Statistics of Epigral Limited
Trade Information | Details |
---|---|
Traded Volume (Lakhs) | 1.26 |
Traded Value (₹ Cr.) | 21.20 |
Total Market Cap (₹ Cr.) | 7,433.25 |
Free Float Market Cap (₹ Cr.) | 2,306.12 |
Impact cost | 0.09 |
Quantity Traded | 126,161.00 |
Deliverable Quantity | 32,823.00 |
% of Quantity to Traded | 26.02 |
Security VaR | 21.52 |
Index VaR | N/A |
VaR Margin | 21.52 |
Extreme Loss Rate | 3.5 |
Adhoc Margin | N/A |
Applicable Margin Rate | 25.02 |
Face Value | 10 |
Key Price Statistics of Epigral Limited
The 52-week high for Epigral Limited was ₹2,406.75, recorded on 03-Oct-2024. On the other hand, the 52-week low stands at ₹950.25, with the lowest value recorded on 15-Mar-2024.
The upper band for trading is ₹1,866.30, and the lower band is ₹1,244.20. The price band is 20%.
The stock's daily volatility stands at 3.25, while the annualized volatility is 62.09. The tick size for trading is ₹0.05.
Price Information | Details |
---|---|
52 Week High (03-Oct-2024) | 2,406.75 |
52 Week Low (15-Mar-2024) | 950.25 |
Upper Band | 1,866.30 |
Lower Band | 1,244.20 |
Price Band (%) | 20 |
Daily Volatility | 3.25 |
Annualised Volatility | 62.09 |
Tick Size | 0.05 |
Key Securities Statistics of Epigral Limited
Securities Information | Details |
---|---|
Status | Listed |
Trading Status | Active |
Date of Listing | 18-Aug-2021 |
Adjusted P/E | 19.35 |
Symbol P/E | 19.35 |
Index | NIFTY TOTAL MARKET |
Macro-Economic Sector | Commodities |
Sector | Chemicals |
Industry | Chemicals & Petrochemicals |
Basic Industry | Specialty Chemicals |
Security Status of Epigral Limited
Title | Details |
---|---|
Board Status | Main |
Trading Segment | Normal Market |
Session No. | - |
Class of Shares | Equity |
SDD Compliance | - |
Name of Compliance Officer | - |
Announcements of Epigral Limited
Subject | Date |
---|---|
Analysts/Institutional Investor Meet/Con. Call Updates | 01-Mar-2025 |
Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent | 28-Feb-2025 |
Cessation | 28-Feb-2025 |
Appointment | 28-Feb-2025 |
Analysts/Institutional Investor Meet/Con. Call Updates | 06-Feb-2025 |
Analysts/Institutional Investor Meet/Con. Call Updates | 31-Jan-2025 |
Analysts/Institutional Investor Meet/Con. Call Updates | 30-Jan-2025 |
Copy of Newspaper Publication | 28-Jan-2025 |
Corporate Actions of Epigral Limited
Face Value | Purpose | Ex-Date |
---|---|---|
10 | Interim Dividend - Rs 2.50 Per Share | 07-Feb-2025 |
10 | Annual General Meeting/Dividend - Rs 5 Per Share | 02-Jul-2024 |
10 | Dividend - Rs 2.50 Per Share | 20-Jun-2023 |
10 | Annual General Meeting | 20-Jun-2023 |
10 | Interim Dividend - Rs 2.50 Per Share | 01-Feb-2023 |
10 | Annual General Meeting | 17-Jun-2022 |
10 | Annual General Meeting | 15-Sep-2021 |
Board Meetings of Epigral Limited
Financial Results of Epigral Limited
Company Directory of Epigral Limited
Web Address | Office | Address | City |
---|---|---|---|
N/A | Head Office/ Corporate Office | MEGHMANI HOUSE B/H, SAFAL PROFITAIRE CORPORATE ROAD PRAHLADNAGAR | AHMEDABAD |
N/A | Registered Office | Epigral Tower, B/h. Safal Profitaire, Corporate Road, Prahladnagar, Ahmedabad, | AHMEDABAD |
N/A | Transfer Agent | Link Intime India Pvt. Ltd., C-101, 247 Park, LBS.Marg, Vikhroli (West), MUMBAI | MUMBAI |
Insider Trading of Epigral Limited
Reg. Clause | Acq./Disp. | Sec. Value | Txn Type |
---|---|---|---|
7(2) | RAMESHBHAI MEGHJIBHAI PATEL | 4837838 | Buy |
7(2) | RAMESHBHAI MEGHJIBHAI PATEL | 4602296 | Buy |
7(2) | MAULIK JAYANTIBHAI PATEL | 719049 | Buy |
7(2) | MAULIK JAYANTIBHAI PATEL | 1778388 | Buy |
7(2) | MAULIK JAYANTIBHAI PATEL | 4284811 | Buy |
7(2) | MAULIK JAYANTIBHAI PATEL | 4838333 | Buy |
7(2) | MAULIK JAYANTIBHAI PATEL | 1313602 | Buy |
7(2) | MAULIK JAYANTIBHAI PATEL | 1986354 | Buy |
7(2) | MAULIK JAYANTIBHAI PATEL | 5064450 | Buy |
7(2) | MAULIK JAYANTIBHAI PATEL | 3981903 | Buy |
7(2) | MAULIK JAYANTIBHAI PATEL | 1452672 | Buy |
7(2) | MAULIK JAYANTIBHAI PATEL | 1658912 | Buy |
7(2) | MAULIK JAYANTIBHAI PATEL | 1658912 | Buy |
7(2) | MAULIK JAYANTIBHAI PATEL | 2853618 | Buy |
7(2) | RAMESHBHAI MEGHJIBHAI PATEL | 5013282 | Buy |
7(2) | DHIREN MADHUR GOYAL | 761280 | Buy |
7(2) | KRUTI ADESH PATEL | 395486 | Buy |
7(2) | ADESH KIRITKUMAR PATEL | 395486 | Buy |
7(2) | KAUSHAL ASHISHBHAI SOPARKAR | 799038 | Buy |
7(2) | KAUSHAL ASHISHBHAI SOPARKAR | 314087 | Buy |
Annual Reports of Epigral Limited
Company | From Year | To Year | Att. |
---|---|---|---|
Epigral Limited | 2023 | 2024 | |
Epigral Limited | 2022 | 2023 | |
Epigral Limited | 2021 | 2022 | |
Epigral Limited | 2020 | 2021 |
Investor Complaints of Epigral Limited
Event Calendar of Epigral Limited
Purpose | Details |
---|---|
Financial Results | To consider and approve the financial results for the period ended September 30, 2021 |
Financial Results | To consider and approve the financial results for the period ended December 31, 2021 |
Other business matters | Revised Intimation for additional agenda to shift Registered Office of the Company to be considered at the Board Meeting of Meghmani Finechem Limited to be held on Monday, 24th January, 2022. |
Financial results | Meghmani Finechem Limited has informed the Exchange about Board Meeting to be held on 25-Apr-2022 to consider financial statements for the period ended March 2022 |
Financial results | Meghmani Finechem Limited has informed the Exchange about Board Meeting to be held on 21-Jul-2022 to consider financial statements for the period ended on 30 June 2022 |
Financial results | Meghmani Finechem Limited has informed the Exchange about Board Meeting to be held on 20-Oct-2022 to consider unaudited financial statements for the period ended September 2022 |
Financial Results/Dividend | To consider and approve the financial results for the period ended December 31, 2022 and dividend |
Financial Results/Dividend | Intimation of the Board Meeting of Meghmani Finechem Limited scheduled to be held on Tuesday, 25th April, 2023 for consideration & approval of Audited Financial Results and recommendation of Final Dividend, if any. |
Financial Results | To consider and approve the financial results for the period ended Jun 30, 2023 |
Financial Results | To consider and approve the financial results for the period ended September 30, 2023 |
Financial Results | To consider and approve the financial results for the period ended December 31, 2023 |
Financial Results/Dividend | To consider and approve the financial results for the period ended March 31, 2024 and dividend |
Financial Results | To consider and approve the financial results for the period ended Jun 30, 2024 |
Fund Raising | To consider Fund Raising |
Financial Results | To consider and approve the financial results for the period ended September 30, 2024 |
Financial Results/Dividend | To consider and approve the financial results for the period ended December 31, 2024 and dividend |
Share Transfers of Epigral Limited
Voting Results of Epigral Limited
Date of Mtg. | Mtg. Type | Resolution |
---|---|---|
16-SEP-2024 | Postal Ballot | To approve fund raising by way of issuance of equity shares and/or equity linked securities for an aggregate amount up to Rs. 500 Crore. n |
09-JUL-2024 | AGM | (a): To receive, consider, and adopt the Audited Standalone Financial Statement of the Company for the Financial Year ended on 31st March, 2024 together with reports of the Board of Directors & Auditors thereon; and (b): To receive, consider, and adopt the Audited Consolidated Financial Statement of the Company. nfor the Financial Year ended on 31st March, 2024 together with reports of Auditors thereon. |
09-JUL-2024 | AGM | To declare a final dividend of Rs 5/- (50%) per equity share of Rs. 10/- each for the Financial Year 2023- 2024. |
09-JUL-2024 | AGM | To appoint a director in place of Mr. Ankit Patel (DIN 02180007), who retires by rotation, and being eligible, offers himself for re-appointment. |
09-JUL-2024 | AGM | To appoint a Director in place of Mr. Karana Patel (DIN 01727321), who retires by rotation, and being eligible, offers himself for re-appointment. |
09-JUL-2024 | AGM | Ratification of Appointment of Statutory Auditors. |
09-JUL-2024 | AGM | Ratification of remuneration payable to Cost Auditors of the Company for the financial year 2024-25. |
09-JUL-2024 | AGM | Continuation of Mr. Manubhai Khodidas Patel as a Non-Executive Independent Director of the Company on completion of 75 years of age. |
FAQs on Epigral Limited
Disclaimer: The information provided here is for informational purposes only and should not be considered financial advice. Please do your own research and consult with a financial professional before making any investment decisions.